# Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome

> **NCT02691949** · PHASE2 · UNKNOWN · sponsor: **Kaohsiung Medical University** · enrollment: 54 (estimated)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT02691949
- **Lead sponsor:** Kaohsiung Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02691949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02691949, "Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's Syndrome". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02691949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*